FeNO testing is transforming the way asthma and respiratory conditions are diagnosed and managed. By providing a fast, non-invasive measure of airway inflammation, this innovative technology enables more accurate diagnoses, personalised treatment plans, and improved patient outcomes. As portable FeNO devices become more accessible, they are playing an increasingly important role in modern, point-of-care respiratory care.

Diagnosing asthma can sometimes be challenging. While symptoms such as wheezing, coughing, and shortness of breath are common indicators, confirming the diagnosis often requires additional testing. Traditionally, doctors rely on lung function tests such as spirometry, peak flow monitoring, and bronchodilator response tests. These methods focus on identifying changes in airway function. However, these tests do not always detect asthma, particularly in patients with mild sympto

Breath testing is a powerful, non-invasive diagnostic tool, but accurate results depend on correct sampling. Learn why breath-holding and end-tidal samples are essential for reliable breath analysis.